Patent · US Active

Modulation of STAT5 expression

US7709628B2 · kind B2 · utility

3Cited by
11References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 3, 2006
Grant dateMay 4, 2010
Priority date
Expiry dateNov 3, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/345
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Compounds, compositions and methods are provided for modulating the expression of STAT5. The compositions comprise oligonucleotides, targeted to nucleic acid encoding STAT5. Methods of using these compounds for modulation of STAT5 expression and for diagnosis and treatment of diseases and conditions associated with expression of STAT5 are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.